INDUSTRY NEWS: Remix Therapeutics reports encouraging clinical progress for its first-in-class MYB mRNA degrader REM-422 - Meet Them In November

INDUSTRY NEWS: Evotec announces a recent CRYO-EM breakthrough using structural biology - Explore These New Approaches in November